In Italy, the indirect costs account for the highest cost for management of RA patients. Considering that costs increase with RA progression, the patients who show a rapid evolution of the functional damages should be identified early based on risk indicators
A multicenter cost-of-illness study on rheumatoid arthritis in Italy / Leardini, G; Salaffi, Fausto; Montanelli, R; Gerzeli, S; Canesi, B.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 20 (4):(2002), pp. 505-515.